Detalhe da pesquisa
1.
Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review.
BJU Int
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658182
2.
Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones.
Cochrane Database Syst Rev
; 7: CD012607, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503906
3.
Immunotherapy for advanced or metastatic urothelial carcinoma.
Cochrane Database Syst Rev
; 10: CD013774, 2023 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37811690
4.
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials.
Urol Int
; 107(5): 480-488, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630942
5.
Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer.
World J Urol
; 40(6): 1437-1446, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347412
6.
Predictors for the utilization of social service counseling by prostate cancer patients.
Support Care Cancer
; 30(3): 2327-2339, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738162
7.
Transplant Ureteral Stenosis after Renal Transplantation: Risk Factor Analysis.
Urol Int
; 106(5): 518-526, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781290
8.
Geriatric Assessments Can Predict Functional Outcome and Mortality after Urological Tumor Surgery.
Urol Int
; 106(8): 848-857, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537771
9.
Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment.
World J Urol
; 39(1): 27-36, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040715
10.
Degarelix for treating advanced hormone-sensitive prostate cancer.
Cochrane Database Syst Rev
; 8: CD012548, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350976
11.
Taguchi versus Lich-Grégoir Extravesical Ureteroneocystostomy in Kidney Transplantation: A Systematic Review.
Urol Int
; 105(11-12): 1052-1060, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537774
12.
Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
Cochrane Database Syst Rev
; 12: CD013245, 2020 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314020
13.
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.
Cochrane Database Syst Rev
; 1: CD011935, 2020 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912907
14.
Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
Cochrane Database Syst Rev
; 6: CD003506, 2019 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194882
15.
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.
Cochrane Database Syst Rev
; 7: CD012838, 2018 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30036453
16.
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.
Cochrane Database Syst Rev
; 5: CD012045, 2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485814
17.
How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience.
Urol Int
; 98(3): 262-267, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376673
18.
Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review.
BJU Int
; 116(1): 30-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25523493
19.
Evidence-based medicine in urology.
World J Urol
; 38(3): 515-516, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32112241
20.
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
Cochrane Database Syst Rev
; (6): CD009266, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24979481